Excess death estimates compared with state-reported and observed COVID-19 deaths, New Jersey and the United States, 2020–2022
Diana Reichbind, Lemlem Mehari, Mojisola Ojo, Nagla Bayoumi, Edward Lifshitz

TL;DR
This study compares reported and excess death estimates for New Jersey and the U.S. during the 2020–2022 pandemic to assess the accuracy of COVID-19 mortality data.
Contribution
The study highlights how New Jersey's detailed reporting system aligns closely with excess death estimates, unlike the U.S. as a whole.
Findings
New Jersey's reported deaths slightly exceeded its excess death estimates for 2020–2022.
U.S. reported deaths did not match the estimated excess deaths for the same period.
New Jersey's early classification system may have improved the accuracy of its death reporting.
Abstract
Deaths associated with COVID-19 in the United States are currently estimated to be over 1.2 million, but the true burden of mortality due to the SARS-CoV-2 virus is unknown. Methods for identifying and reporting deaths related to COVID-19 differ between jurisdictions, and concerns about overreporting and underreporting exist. Excess death estimates for the pandemic period, based on data from the National Center for Health Statistics, may be used to approximate the number of COVID-19-associated deaths. In this analysis, we first describe the process by which the New Jersey Department of Health identified, classified, and reported COVID-19-associated deaths from January 2020 through December 2022. The National Center for Health Statistics’ excess deaths estimates are first compared with New Jersey’s reported COVID-19-associated deaths, and then with the observed COVID-19-associated deaths…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts · Healthcare cost, quality, practices · COVID-19 epidemiological studies
